Abstract P098 – Table 1. Baseline demographic and clinical characteristics of the 1237 PLWHIV switching to BIC/FTC/TAF in the Icona cohort.
	ART‐experienced VS (N = 1237)
Italian, n (%)	1043	(84.3)
Ethnicity, Caucasian, n (%)	1102	(89.1)
Gender, female, n (%)	229	(18.5)
Year of BIC start, median (IQR)	2019	(2019 to 2020)
Year cART start, median (IQR)	2015	(2011 to 2017)
Age, years, median (IQR)	47	(39 to 55)
− Age, >50 years, n (%)	544	(43.98)
Mode of HIV transmission, n (%)
Heterosexual	456	(36.86)
IVDU	100	(8.08)
MSM	622	(50.28)
Other/unknown	59	(4.77)
HCVAb positive status, n (%)	129	(10.43)
HBsAg positive status, n (%)	49	(3.96)
Previous AIDS, n (%)	203	(16.41)
CD4, cells/mmc, median (IQR)	702	(505 to 928)
CD4 <200 cells/mmc, n (%)	28	(2.26)
CD4 <350 cells/mmc, n (%)	140	(11.3)
CD4/CD8 ratio, median (IQR)	0.87	(0.59 to 1.22)
HIV‐RNA, copies/mL, median (IQR)	2	(1 to 24)
LDL cholesterol, mg/dL, median (IQR)	120	(100 to 145)
HDL cholesterol, mg/dL, median (IQR)	49	(41 to 58)
Triglycerides, mg/dL, median (IQR)	116	(83 to 168)
Serum glucose, mg/dL, median (IQR)	88	(81 to 96)
eGFR, CKD‐EPI, mL/min, median (IQR)	89.5	(77.2 to 101.8)
Weight, kg, median (IQR)	74	(66 to 82)
BMI, kg/m2, median (IQR)	24.2	(22.2 to 26.9)
Follow‐up on BIC, years, median (IQR)	1.37	(0.97 to 1.67)
Previous ART regimen
INSTI‐based	1061	(85.77)
NNRTI‐based	95	(7.68)
PI‐based	62	(5.01)
Other	19	(1.54)